Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Discover which credit cards provide the best points redemption options. Make informed choices to maximize your rewards potential.
25,829 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A large investor reportedly exited a sizable MercadoLibre position, triggering headlines about the move. This article...
Structure Therapeutics stock has surged after a major hedge fund increased its stake. This article breaks down what s...
As kontoor brands (ktb) 2025 unfolds, investors are weighing margins, brand strength, and growth channels. This artic...
Could XRP realistically reach $100? This article breaks down the math, the regulatory headwinds, real-world use cases...
As AI workloads rise, memory stocks grab attention. This guide lays out three scenarios for where will micron stock b...
Tesla shares slipped as three major developments tug the stock in mixed directions: stricter autonomous driving overs...
Hyperscale AI demand is tightening packaging capacity. Intel's EMIB-T presents a potential workaround as chip packagi...
Jefferies boosts Palo Alto Networks price target to $265 with a Buy rating as AI-driven threats compress attack timel...
DEI labels face political heat, but industry leaders argue the underlying work remains essential for growth and talen...
Year-end is a prime time to fine-tune your investments. Discover three practical portfolio moves stock market investo...
Microsoft’s stock has drifted lower this year even as its AI and cloud businesses show stronger momentum. This piece ...